ICU vs NEPH
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 23, 2026
ICU
NEPH
Investment Advisor Scores
NEPH
AI Analyst Insights
Detailed Metrics Comparison
| Metric | ICU | NEPH | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 0 | 0 | Tie |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 82.0% | 36.2% | ICU |
| Earnings Growth | 0.0% | 450.0% | NEPH |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 45.2/100 | 60.8/100 | NEPH |
| Profit Margin | 0.0% | 8.4% | NEPH |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | STRONG BUY | NEPH |
Relative Price Performance (Last 90 Days)
Current Technical Phase
ICU
MarkdownPrice below a falling SMA50 (slope -0.8%), weak momentum, RSI 37
NEPH
MarkdownPrice below a falling SMA50 (slope -2.0%), weak momentum, RSI 44
Fundamentals Snapshot
| Metric | ICU | NEPH |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -1.0 | 16.8 |
| Trailing P/E | — | 23.5 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.8% | 0.4% |
| Gross Margin | 0.9% | 0.6% |
| Operating Margin | -6.2% | 0.2% |
| EPS | -2.97 | 0.15 |
| Dividend Yield | — | — |